[Endocrine and cytostatic treatment of metastazing breast carcinoma in the female].
D000315:Adrenalectomy; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy*; D002369:Castration; D003520:Cyclophosphamide / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007016:Hypophysectomy; D008722:Methods; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D013326:Strontium Radioisotopes / Q000378:metabolism
D045930:Anabolic Agents; D000728:Androgens; D000970:Antineoplastic Agents; D004967:Estrogens; D013326:Strontium Radioisotopes; D004997:Ethinyl Estradiol; D003520:Cyclophosphamide
Die endokrine und zytostatische Behandlung des mestastasierenden Mammakarzinoms der Frau